Alteration of ceramide 1-O-functionalization as a promising approach for cancer therapy

Area of Science:

• Biochemistry
• Cell Biology
• Oncology

Background:

• Sphingolipids are crucial cell membrane components regulating trans-membrane signaling and stress adaptation.
• In cancer, altered sphingolipid metabolism, with reduced apoptosis-inducing ceramides and increased tumor-promoting metabolites, is common.
• Modulating sphingolipid pathways presents a promising avenue for novel cancer therapies.

Purpose of the Study:

• To review chemical entities targeting ceramide metabolism for cancer therapy.
• To focus on enzymes modifying ceramide at the C1-OH position.
• To discuss the impact of enzyme inhibitors on cancer progression and drug resistance.

Main Methods:

• Literature review of findings on chemical entities targeting sphingolipid metabolism.
• Analysis of enzyme inhibitors affecting ceramide metabolism.
• Presentation of effects on cancer cell proliferation, apoptosis, and drug sensitivity.

Main Results:

• Specific enzyme inhibitors targeting sphingomyelin synthase, ceramide kinase, and glucosylceramide synthase were identified.
• These inhibitors demonstrate effects on cancer cell proliferation and apoptosis induction.
• Impact on sensitivity to chemotherapeutics and xenograft growth was observed.

Conclusions:

• Targeting enzymes involved in ceramide metabolism offers potential for cancer treatment.
• Inhibitors of sphingomyelin synthase, ceramide kinase, and glucosylceramide synthase show promise.
• Further development of these chemical entities could lead to novel pharmacological tools for cancer therapy.